Boston gains FDA OK for bile duct stent:
This article was originally published in Clinica
Executive Summary
Boston Scientific has gained US FDA clearance to sell its Express biliary LD pre-mounted stent system for alleviating malignant biliary obstruction - a blockage in any ducts that carries bile from the liver to the gallbladder and on to the small intestine. The system incorporates Boston's Tandem Architecture stent design with Ultra-thin SDS balloon catheter technology. The low profile, balloon-expandable stent comes in a wide range of sizes, says the Natick, Massachusetts firm.
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.